{"id":"https://openalex.org/W2332021233","doi":"https://doi.org/10.1097/00042560-199904010-00035","title":"PHOSPHORYLATION OF P53: A NOVEL PATHWAY FOR P53 INACTIVATION IN HTLV-I-TRANSFORMED CELLS","display_name":"PHOSPHORYLATION OF P53: A NOVEL PATHWAY FOR P53 INACTIVATION IN HTLV-I-TRANSFORMED CELLS","publication_year":1999,"publication_date":"1999-04-01","ids":{"openalex":"https://openalex.org/W2332021233","doi":"https://doi.org/10.1097/00042560-199904010-00035","mag":"2332021233"},"language":"en","primary_location":{"id":"doi:10.1097/00042560-199904010-00035","doi":"https://doi.org/10.1097/00042560-199904010-00035","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00042560-199904010-00035","pdf_url":null,"source":{"id":"https://openalex.org/S4210183002","display_name":"Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology","issn_l":"1077-9450","issn":["1077-9450","2331-6993"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-b","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015633898","display_name":"Cynthia A. Pise-Masison","orcid":"https://orcid.org/0000-0003-2788-235X","observed_orcids":["https://orcid.org/0000-0003-2788-235X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cynthia A. Pise-Masison","raw_affiliation_strings":["Virus Tumor Biology Section, Divison of Basic Sciences, National Cancer Institute, Bethesda, Maryland 20892-5055"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virus Tumor Biology Section, Divison of Basic Sciences, National Cancer Institute, Bethesda, Maryland 20892-5055","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111432397","display_name":"Michael F. Radonovich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Radonovich","raw_affiliation_strings":["Virus Tumor Biology Section, Divison of Basic Sciences, National Cancer Institute, Bethesda, Maryland 20892-5055"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virus Tumor Biology Section, Divison of Basic Sciences, National Cancer Institute, Bethesda, Maryland 20892-5055","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109269727","display_name":"John N Brady","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Brady","raw_affiliation_strings":["Virus Tumor Biology Section, Divison of Basic Sciences, National Cancer Institute, Bethesda, Maryland 20892-5055"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virus Tumor Biology Section, Divison of Basic Sciences, National Cancer Institute, Bethesda, Maryland 20892-5055","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.24097767,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"20","issue":"4","first_page":"A11","last_page":"A11"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.923799991607666,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.923799991607666,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12159","display_name":"T-cell and Retrovirus Studies","score":0.0681999996304512,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10934","display_name":"Heat shock proteins research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p53-phosphorylation","display_name":"p53 phosphorylation","score":0.996999979019165},{"id":"https://openalex.org/keywords/htlv-1","display_name":"HTLV-1","score":0.8320000171661377},{"id":"https://openalex.org/keywords/p53-inactivation","display_name":"p53 inactivation","score":0.8090000152587891},{"id":"https://openalex.org/keywords/tax-protein","display_name":"Tax protein","score":0.597000002861023},{"id":"https://openalex.org/keywords/post-translational-modification","display_name":"post-translational modification","score":0.8190000057220459},{"id":"https://openalex.org/keywords/t-cell-acute-lymphoblastic-leukemia","display_name":"T-cell acute lymphoblastic leukemia","score":0.7850000262260437},{"id":"https://openalex.org/keywords/viral-carcinogenesis","display_name":"viral oncogenesis","score":0.6340000033378601},{"id":"https://openalex.org/keywords/tumor-suppressor-genes","display_name":"tumor suppressor","score":0.734000027179718}],"concepts":[{"id":"https://openalex.org/C102622118","wikidata":"https://www.wikidata.org/wiki/Q18031819","display_name":"TAF1","level":5,"score":0.843498170375824},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.7291129231452942},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5235240459442139},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.46929293870925903},{"id":"https://openalex.org/C2779933727","wikidata":"https://www.wikidata.org/wiki/Q7187535","display_name":"Phosphopeptide","level":3,"score":0.4526784121990204},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.44543248414993286},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.44024598598480225},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2791701555252075},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2325994074344635},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.1207493245601654},{"id":"https://openalex.org/C101762097","wikidata":"https://www.wikidata.org/wiki/Q224093","display_name":"Promoter","level":4,"score":0.11937302350997925}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/00042560-199904010-00035","doi":"https://doi.org/10.1097/00042560-199904010-00035","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00042560-199904010-00035","pdf_url":null,"source":{"id":"https://openalex.org/S4210183002","display_name":"Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology","issn_l":"1077-9450","issn":["1077-9450","2331-6993"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-b","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.5683000087738037,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2138059125","https://openalex.org/W2024128408","https://openalex.org/W2169499958","https://openalex.org/W2327720452","https://openalex.org/W2410889253","https://openalex.org/W2275722545","https://openalex.org/W2045364645","https://openalex.org/W2427589873","https://openalex.org/W2174255877","https://openalex.org/W2164208359"],"abstract_inverted_index":{"O-14":[0],"Inhibition":[1],"of":[2,23,43,106,109,121,151,163],"p53":[3,31,35,51,89,110,152],"function,":[4],"either":[5],"through":[6],"mutation":[7],"or":[8],"interaction":[9],"with":[10,16,100],"viral":[11,62],"transforming":[12],"proteins,":[13],"correlates":[14],"strongly":[15],"oncogenic":[17],"potential.":[18],"Only":[19],"a":[20,93],"small":[21],"percentage":[22],"human":[24],"T-lymphotropic":[25],"virus":[26],"type-I-(HTLV-I)":[27],"transformed":[28],"cells":[29],"carry":[30],"mutations":[32],"and":[33,54,80,132,137,165,176],"mutated":[34],"genes":[36],"have":[37,47,76],"been":[38],"found":[39],"in":[40,57,84,92,153],"only":[41],"one-fourth":[42],"ATL":[44],"cases.":[45],"We":[46],"demonstrated":[48],"that":[49,78,119,145],"wild-type":[50],"is":[52],"stabilized":[53],"transcriptionally":[55],"inactive":[56],"HTLV-transformed":[58],"cells.":[59,86],"Further,":[60],"the":[61,67,107,148,157],"transcriptional":[63],"activator":[64],"Tax":[65],"inactivates":[66],"N-terminal":[68],"activation":[69],"domain.":[70],"Using":[71,114],"phospho-amino":[72],"acid-specific":[73],"antibodies,":[74],"we":[75,102,117],"shown":[77],"Ser15":[79,122,131],"Ser392":[81],"are":[82,168],"hyper-phosphorylated":[83],"HTLV-I-transformed":[85],"Since":[87],"HTLV-I":[88,146],"binds":[90],"DNA":[91],"sequence-specific":[94],"manner":[95],"but":[96],"fails":[97],"to":[98,155],"interact":[99],"TFIID,":[101],"tested":[103],"whether":[104],"phosphorylation":[105,120,129],"N-terminus":[108],"affected":[111],"p53-TFIID":[112,125],"interaction.":[113,126],"biotinylated":[115],"peptides":[116],"show":[118],"alone":[123],"inhibits":[124],"In":[127],"contrast,":[128],"at":[130],"37":[133],"restores":[134],"TFIID":[135],"binding":[136],"blocks":[138],"MDM2":[139],"binding.":[140],"Our":[141],"studies":[142],"provide":[143],"evidence":[144],"utilizes":[147],"post-translational":[149],"modification":[150],"vivo":[154],"inactivate":[156],"tumor":[158],"suppressor":[159],"protein.":[160],"The":[161],"importance":[162],"ATM":[164],"DNA-PK":[166],"kinases":[167],"being":[169],"addressed":[170],"using":[171],"kinase":[172],"deficient":[173],"cell":[174],"lines":[175],"GAL4-p53":[177],"fusion":[178],"proteins.":[179]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}